Key result
US commercially insured patients with type 1 diabetes had a diabetic ketoacidosis incidence of 55.5 per 1000 person-years, decreasing 6.1% annually in 2018-2019 after increasing since 2011.
In US commercially insured patients with T1DM, the incidence of DKA was 55.5 per 1000 person-years, with a recent decrease in 2018-2019 following years of steady increase.
DKA incidence trends in T1DM merit continued surveillance; leaves open questions on drivers of recent decline and generalizability.
Diabetic ketoacidosis (DKA) is a common complication of type 1 diabetes mellitus (T1DM). We found that the incidence of DKA was 55.5 per 1000 person-years in US commercially insured patients with T1DM; age-sex-standardized incidence decreased at an average annual rate of 6.1% in 2018-2019 after a steady increase since 2011.
No takes yet. Share an insight, caveat, or question.
Li et al. (2021) studied this question. US commercially insured patients with type 1 diabetes had a diabetic ketoacidosis incidence of 55.5 per 1000 person-years, decreasing 6.1% annually in 2018-2019 after increasing since 2011.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: